Astellas Pharma, Inc. v. Sandoz Inc.
| ASTELLAS PHARMA, INC., ASTELLAS IRELAND CO., LTD. and ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. |
| SANDOZ INC. |
| 23-2063 |
| June 23, 2023 |
| U.S. Court of Appeals, Federal Circuit |
| Patent - (ANDA) (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 Note to File: The following cases are consolidated: 23-2032 (Lead) with 23-2063, 23-2089 (Members). The parties must file all documents in the lead appeal only. [934455] [23-2063, 23-2089] [ALK] [Entered: 07/06/2023 04:04 PM] |
Filing 2
ORDER consolidating appeals 23-2032, 23-2063, and 23-2089. Appellants' opening brief is due no later than August 28, 2023. Service as of this date by the Clerk of Court. [934452] [23-2032, 23-2063, 23-2089] [ALK] [Entered: 07/06/2023 03:59 PM]
|
| Filing 1 Appeal docketed. Received: 06/22/2023. [931907] Entry of Appearance is due on 07/07/2023. Certificate of Interest is due on 07/07/2023. Docketing Statement is due on 07/07/2023. Appellants' brief is due on 08/22/2023. [ALK] [Entered: 06/23/2023 11:27 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
